Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Swiss Medical Board will discontinue functioning at the end of 2021

17 Sep 2020

On September 7, 2020, the Swiss Medical Board has announced that the organization will discontinue its operations at the end of 2021.

The Swiss Medical Board was created in 2009 as an initiative of the Canton of Zurich. It has been operating nationwide since 2011. The organization has succeeded in establishing HTA as a standard for the evaluation of medical services in Switzerland. The SMB's activities have also prompted the Swiss Government to take action, and the Swiss Government has created its own program of evaluating technologies in order to reduce ineffective and inefficient services.  Thus, the Executive Committee of the Swiss Medical Board concluded that there is no point in maintaining parallel structures in a small country such as Switzerland. Ongoing projects and work will be completed.

See the full news in English here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.